Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6232317

Cl.[O-][S+](Cl)Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL302 0.93
SCHEMBL7126192 0.86
Iodide SCHEMBL5577051 0.86
SCHEMBL31612804 0.86
Ammonia Solution, Strong SCHEMBL15540045 0.86
Methane SCHEMBL1818230 0.86
SCHEMBL34224 0.86
Phosphine SCHEMBL10394278 0.86
Charcoal, Activated SCHEMBL2479918 0.86
SCHEMBL4814228 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110668948-B Preparation method of 4-chloro-2-fluoro-5-nitroacetophenone 苏州敬业医药化工有限公司 2022-03-08 CN disclosed
CN-110668948-A Preparation method of 4-chloro-2-fluoro-5-nitroacetophenone 苏州敬业医药化工有限公司 2020-01-10 CN disclosed
CN-105218436-B A method of preparing 4- Chloro-2-Pyridyle methyl formate 济南诚汇双达化工有限公司 2019-02-05 CN disclosed
CN-108003036-A A kind of preparation method of 2-chloroethyl amine hydrochloride 山东泰和水处理科技股份有限公司 2018-05-08 CN disclosed
CN-107400087-A A kind of preparation method of 1 (2 (4 (chloromethyl) phenoxy group) ethyl) azepan hydrochloride 济南美高生物医药科技有限公司 2017-11-28 CN disclosed
CN-105873932-B (6S,9aS) -N-benzyl-6- [ (4-hydroxyphenyl) methyl ] -4, 7-dioxo-8- ({6- [3- (piperazin-1-yl) azetidin-1-yl ] pyridin-2-yl } methyl) -2- (prop-2-en-1-yl) -octahydro-1H-pyrazino [2,1-c ] [1,2,4] triazine-1-carboxamide compound 卫材R&D管理有限公司 2017-11-24 CN disclosed
CN-106565560-A Synthesis process of mesotrione 湖北广富林生物制剂有限公司 2017-04-19 CN disclosed
CN-106565561-A 2-nitro-4-methylsulfonylbenzoylchloride synthesizing process 湖北广富林生物制剂有限公司 2017-04-19 CN disclosed
CN-106187910-A Pyridazine class derivant and its production and use 浙江大学 2016-12-07 CN disclosed
CN-105873932-A (6S,9aS) -N-benzyl-6- [ (4-hydroxyphenyl) methyl ] -4, 7-dioxo-8- ({6- [3- (piperazin-1-yl) azetidin-1-yl ] pyridin-2-yl } methyl) -2- (prop-2-en-1-yl) -octahydro-1H-pyrazino [2,1-c ] [1,2,4] triazine-1-carboxamide compound 卫材R&D管理有限公司 2016-08-17 CN disclosed
US-6790991-B2 FOMESAFEN PRODUCED BY NITRATING 3-(2-CHLORO-A,A,A-TRIFLUORO-4-TOLYLOXY)-BENZOIC ACID TO FORM ACIFLUORFEN, CONVERTING TO ITS ACID CHLORIDE, AND THEN REACTION WITH METHANESULFONAMIDE SYNGENTA LIMITED (GB) 2004-09-14 US disclosed
US-20030045754-A1 Process for the preparation of diphenyl ether compounds SYNGENTA LIMITED (GB) 2003-03-06 US disclosed
EP-1246796-A1 PROCESS FOR THE PREPARATION OF DIPHENYL ETHER COMPOUNDS Syngenta Limited (GB) 2002-10-09 EP disclosed
WO-2001046130-A1 PROCESS FOR THE PREPARATION OF DIPHENYL ETHER COMPOUNDS SYNGENTA LIMITED (GB) 2001-06-28 WO disclosed
EP-0766687-A1 PHOSPHINIC ACID DERIVATIVES WITH METALLOPEPTIDASE INHIBITORY ACTIVITY ZAMBON GROUP S.p.A. (IT) 1997-04-09 EP disclosed
WO-1995035302-A1 PHOSPHINIC ACID DERIVATIVES WITH METALLOPEPTIDASE INHIBITORY ACTIVITY ZAMBON GROUP S.P.A. (IT) 1995-12-28 WO disclosed
US-4593098-A Piperazinone and piperazine polypeptides THE UPJOHN COMPANY (US) 1986-06-03 US disclosed
US-4534897-A Piperazinone, piperazine, 1,4-diazepin-2-one and 1,4-diazepine intermediate compounds THE UPJOHN COMPANY (US) 1985-08-13 US disclosed
US-4351888-A ELECTROLYTE CONTAINS AN INSOLUBLE ADDITIVE WHICH DISSOLVES WITH INCREASED HEAT TO LIMIT CURRENT GTE LABORATORIES INCORPORATED (US) 1982-09-28 US disclosed
US-4251438-A ANALGESICS, PSYCHOTHERAPEUTIC AGENTS THE UPJOHN COMPANY (US) 1981-02-17 US disclosed